Gloucestershire Health and Care- NHS Trust logo
with you, for you
Archive for Clinical Activity Data > Page 2

Search for a reference number

Clinical Activity Data

Invasive Procedure Data Capture

Under the Freedom of Information Act 2000, I would like to request information regarding clinical documentation practices, specifically in relation to the capture of information during interventional procedures, such as Central Venous Access Device (CVAD) insertions.

1. Clinical Documentation
• What methods are currently used by clinicians to document key information during invasive procedures, such as CVAD insertions (e.g., paper forms, digital forms, voice dictation, other)?
o Is any form of structured digital data entry used at the point of care for these procedures?
• Are standardised templates or proformas used Trust-wide for documenting invasive procedures, such as Local Safety Standards for Invasive Procedures (LocSSIPs)?
o Are any of these LocSSIPs or other forms digitised?

2. Voice Technology
• Does the Trust currently use any voice-to-text or voice recognition technology for clinical documentation (e.g., Dragon Medical One, Nuance, Voice-Care, etc.)?
• If yes, which departments or specialties currently use it, and for which types of documentation?

3. Administrative Efficiency
• Has the Trust undertaken any assessments of the administrative time burden associated with completing procedural documentation (manual or digital)?
o If so, is any information available on time spent per procedure or efforts to streamline the process?

4. Future Plans
• Is the Trust currently planning any initiatives or procurements to digitise documentation processes for interventional procedures?
o If yes, please outline the scope and timelines if available.

read more

Hip Fractures at Minor Injuries Department

I am writing under the Freedom of Information Act 2000 to request information relating to the diagnosis and treatment of hip fractures for patients presenting at your Minor Injuries department, broken down by year, for the past four calendar years (2021, 2022, 2023, 2024) up to and including 03 May 2025:

· The number of patients who presented at Minor Injuries with hip pain and were referred for: X-Ray o MRI scan.

· Of those who underwent an X-ray only, how many had negative or inconclusive results but were later diagnosed with a femoral neck or other hip fracture?

If the request exceeds the cost exemption, as per s12 of the 2000 Act, please advise me on how to amend my request accordingly.

read more

Wait Times and Repeat Referrals

I am submitting this request under the Freedom of Information Act 2000. Please provide the following information:

1. Longest wait times for therapy services. Please provide the longest recorded wait times for local NHS Talking Therapies in 2024.
2. Percentage of patients waiting more than 90 days for their first completed appointment.
3. Repeat referrals within 12 months of discharge. Please provide the number of patients who were discharged from local NHS Talking Therapies but required a repeat referral within 12 months in 2024.
4. Total referrals for local NHS Talking Therapies in the 2024 calendar year.
In the event you can’t respond to all four questions please answer as many as possible taking each in turn, 1-4.

read more

Cancer Treatment

I would be grateful if you could please answer the following question with regards to cancer treatment:

In the last 12 months, how many unique patients in your trust have been treated privately for the following ICD-10 codes?

A) C61 Malignant neoplasm of prostate
B) C16.0 Malignant neoplasm of the gastroesophageal Junction

read more

Admissions Involving the Insertion of Objects

I am writing to request the following information under the Freedom of Information Act:

For the period from January 2019 to the most recent available data, please provide the following details relating to admissions involving the insertion of objects into the anus or vagina.

• The total number of incidents recorded per year.
• The age and gender of the individual involved in each incident (if available and anonymised).
• A brief description of the incident or nature of injury and if the insertion was accidental or deliberate (if available and anonymised).
• The item used – including but not limited to sex toys, household objects, and food.

read more

Colposuspension – Management of Urinary Incontinence in Women

I am conducting a research project to compare the safety and efficacy of permanent versus absorbable sutures in Colposuspension for the management of stress urinary incontinence in women. I would be grateful if you could help me with this data.

From your hospital surgical database, please can you provide us with:
1. the number of Colposuspensions conducted in your unit between January 2020 and January 2025.
Of these, please clarify how many were conducted:
-open
-laparoscopically
-robotically

2. How many of these cases have needed to go back to theatre for any procedure under the care of urogynaecology/gynaecology/urology since the initial operation?
Please state, what procedures they then underwent.

The following questions, may be known by the theatre team via the surgeon’s cardex (information sheet which each surgeon will have with their preference of equipment for each operation) for Colposuspension. In the worst case, it may need to posed to the surgeons who usually perform colposuspensions but should be a quick answer:

“Which suture material is routinely used to suture onto the iliopectineal ligament in open cases? Please state name of suture or N/A if this route of colposuspension is not performed.”

“Which suture material is routinely used to suture onto the iliopectineal ligament in laparoscopic cases? Please state name of suture or N/A if this route of colposuspension is not performed.”

“Which suture material is routinely used to suture onto the iliopectineal ligament in robotic cases? Please state name of suture or N/A if this route of colposuspension is not performed.”

read more

283-2024

,

1. Does your trust have an AKI lead? (Yes/No)
2. Do you use an AKI bundle for patient care within your trust? (Yes/ No)
– If so what care bundle do you use?
3. Are you a paperless trust? (Yes/No)
4. What electronic system do you use for electronic noting?
5. Is your electronic noting system used for all healthcare professions within the organisation? (Yes/No)
6. Do you have AKI nurses within your trust? (Yes/No)
-If so- how many? Are they clinical nurse specialists, advanced practitioners, or another role title?
-Does their role banding meet national standards (Qualified Advanced Clinical Practitioners 8a, Trainee Advanced Clinical Practitioners- band 7, Lead Clinical Nurse Specialists – band 7,Clinical Nurse Specialist- band 6)? (Yes/No)
7. Does your trust have a renal unit? (Yes/No)
8. How many adult inpatient beds does your trust have?

read more

272-2024

,

Please can you advise the total number of patients that have been referred to the Heart Failure Diagnostics Clinic within your trust for the following years: 2022, 2023, 2024

read more

274-2024

,

1. In the past three years, how many patients aged 65 and above attended/were admitted to a hospital apart of the trust with health problems related to cold temperatures, such as chest infections, respiratory conditions, flu, hypothermia and others? (Broken down by years: 2022, 2023, 2024)
2. How many excess winter deaths (EWDs) have the trust recorded in the past three years? (Broken down by years: 2022, 2023, 2024)
3. Of these deaths, how many were aged 65 and above? (Broken down by years: 2022, 2023, 2024)

read more

261-2024

, ,

Q1 Trust Name:
Q2 Type of Healthcare Facilities
o District General Hospital (DGH) (1)
o Specialty Hospital (2)
o Private Hospital (3)
o Community Hospital (4)
o Other (Please Specify) (5)
Q3 Demographic of Hospital Care
o Adult Hospital (1)
o Paediatric Hospital (2)
o General Hospital (Both paediatric and adult) (3)
o GP surgery (4)
o Other (Please Specify) (5)
Q4 Respondent’s Role in the Trust:
o Medical Records Manager (1)
o IT Specialist (2)
o Clinician (3)
o Administrator (4)
o Other (Please Specify) (5)
Q5 Does your Trust use electronic patient records (EPR)?
o Yes (1)
o No (2)
Q6 Which EPR system does your Trust use?
▢ Cerner (1)
▢ Epic (2)
▢ System C (3)
▢ Dedalus (4)
▢ Altera (5)
▢ Other (Please Specify (6)
Q7 Does the EPR system used by your Trust include a specific section for recording food, drug, latex, and other allergies?
o Yes (1)
o No (2)
Q8 If yes to question 7, how is the initial allergy information typically entered into the system? (Select all that relevant)
▢ Manually by Doctor (1)
▢ Manually by Pharmacist (5)
▢ Manually by Nurse (6)
▢ Manually by Dietitian (7)
▢ Automatically from Previous Records (2)
▢ Manually by Administrative Staff (3)
▢ Other (Please Specify) (4)
Q9 If yes to question 7, who is responsible for updating and/or checking allergy information in the patient’s electronic record? (Select all that apply)
▢ Clinicians (e.g., doctors, nurses) (1)
▢ Administrative Staff (2)
▢ Pharmacists (3)
▢ IT/Technical Support Staff (4)
▢ Don’t Know (5)
▢ Other (Please Specify) (6)
Q10 How is the allergy information flagged or highlighted in the patient’s records to alert healthcare providers?
o Red Flag (1)
o Pop-up Alert (2)
o Highlighted Text (3)
o Other (Please Specify) (4)
o Not highlighted/ alerted on the system (5)
Q11 What training, if any, is provided to staff on the correct recording of allergies in patient records?
o Mandatory Training Sessions (1)
o Optional Training (2)
o No Training Provided (3)
o Other (Please Specify) (4)
Q12 If training is provided on allergy documentation, does it specifically cover different types of allergies in the training materials?
o Only drug allergy recording (1)
o Both drug and non-drug allergy recording (2)
o Drug, food, and other non-drug allergy recording (e.g., latex) (3)
o Don’t know/ Unsure (4)
Q13 Does your Trust have a Local Guideline or Standard Operating Procedure (SOP) in place covering allergy documentation on the EPR?
o Yes (3)
o No (5)
o Don’t know/ Unsure (4)
Q14 If yes to Question 13, does this guideline/SOP include documentation for allergens below? (Select all that relevant)
▢ Drugs (1)
▢ Food (2)
▢ Other non-drug substances (e.g. latex) (3)
▢ Don’t know/ Unsure (5)
Q15 Does your hospital have access to specialist allergy advice for paediatric patients?
o Yes, please specify if this service available is available through In-House, Local Centre or Regional Centre. (1)
o No (2)
Q16 Does your hospital have access to specialist allergy advice for adult patients?
o Yes, please specify if this service available is available through In-House, Local Centre or Regional Centre. (1)
o No (2)
Q17 Does the incident reporting platform have a specific category for recording food or other non-drug allergy incidents?
o Yes (1)
o No (2)
Q18 In the last 10 years, has your Trust recorded any incidents where a patient was administered a food, drug, or other substance (e.g., latex) they were known to be allergic to?
o Yes (1)
o No (2)
Q19 If yes to question 18, how many such incidents have been reported in the last 10 years? [Numerical Response]
o <5, please specify (1)
o 5 – 9, please specify (2)
o 10 – 19, please specify (3)
o ≥ 20, please specify (4)
o Don’t know (5)
Q20 If yes to question 18, please indicate the number of incidents for each category: [Numerical Response]
▢ Drug allergy incidents (1)
▢ Food allergy incidents (2)
▢ Incidents to other allergic substances (3)
▢ Don’t know/ unaware (4)
Q21 Considering the start date of your EPR system, how many years’ worth of incident data have you been able to search for this survey? Ideally, up to 10 years. (e.g. 2014 – 2024)
Q22 For reported DRUG ALLERGY incidents, what are the drugs involved, age group (≤17 or >17 years), and level of harm (no harm, low harm, moderate harm, severe harm or death), listing up to 10 cases prioritized by severity of harm, followed by the most recent incidents?
Please indicate the total cases below if more than 10 cases were reported.
Example: Case 1 (Amoxicillin, >17yo, low harm).
▢ Case 1 (allergen, age, level of harm) (1)
▢ Case 2 (allergen, age, level of harm) (2)
▢ Case 3 (allergen, age, level of harm) (3)
▢ Case 4 (allergen, age, level of harm) (4)
▢ Case 5 (allergen, age, level of harm) (5)
▢ Case 6 (allergen, age, level of harm) (7)
▢ Case 7 (allergen, age, level of harm) (8)
▢ Case 8 (allergen, age, level of harm) (9)
▢ Case 9 (allergen, age, level of harm) (10)
▢ Case 10 (allergen, age, level of harm) (11)
▢ If more than 10 cases are reported, please indicate the total number of cases below. (13)
▢ No drug allergy incidents reported (14)
Q23 For reported FOOD and OTHER NON-DRUG ALLERGY incidents, what are the allergens involved, age (confirm age via clinical record if required), reactions, if serious incident reported and level of harm (no harm, low harm, moderate harm, severe harm or death), listing up to 10 cases prioritized by severity of harm, followed by the most recent incidents?
Please indicate the total cases below if more than 10 cases were reported.
Example: Case 1 (Peanut, 3yo, anaphylaxis, serious incident reported, moderate harm).
▢ Case 1 (allergen, age, reaction, serious incident reported, level of harm) (1)
▢ Case 2 (allergen, age, reaction, serious incident reported, level of harm) (2)
▢ Case 3 (allergen, age, reaction, serious incident reported, level of harm) (3)
▢ Case 4 (allergen, age, reaction, serious incident reported, level of harm) (4)
▢ Case 5 (allergen, age, reaction, serious incident reported, level of harm) (5)
▢ Case 6 (allergen, age, reaction, serious incident reported, level of harm) (7)
▢ Case 7 (allergen, age, reaction, serious incident reported, level of harm) (8)
▢ Case 8 (allergen, age, reaction, serious incident reported, level of harm) (9)
▢ Case 9 (allergen, age, reaction, serious incident reported, level of harm) (10)
▢ Case 10 (allergen, age, reaction, serious incident reported, level of harm) (11)
▢ If more than 10 cases report, please indicate the total number of cases below. (13)
▢ No food allergy OR other non-drug allergy incidents reported (14)
Q24 For FOOD AND OTHER NON-DRUG ALLERGY incidents, how many of the incidents was the allergen clearly documented in patients notes/correspondence prior to the incident? Please insert the number of cases involved in each category. (e.g. 0 – 100)
▢ Food allergies documented correctly, please specify: (1)
▢ Food allergies not documented, please specify: (2)
▢ Non-drug allergies documented correctly, please specify: (3)
▢ Non-drug allergies not documented, please specify: (4)
▢ The food/ non-drug allergens were not previously known (7)
Q25 For FOOD AND OTHER NON-DRUG ALLERGY incidents, how many of the incidents was the allergen correctly documented on the relevant field in EPR prior to incident (Cerner / Epic / Other)? Please insert the number of cases involved in each category. (e.g. 0 – 100)
▢ Food allergies documented correctly, please specify: (1)
▢ Food allergies not documented, please specify: (2)
▢ Non-drug allergies documented correctly, please specify: (3)
▢ Non-drug allergies not documented, please specify: (4)
▢ The food/ non-drug allergens were not previously known (5)
Q26 What were the causes identified in the food or other non-drug incidents? (Multiple answers allowed)
▢ Allergy not recorded in EPR (1)
▢ Allergy recorded but not flagged/alerted (2)
▢ Staff did not check EPR (3)
▢ Incorrect substance administered due to similar names/packaging (4)
▢ System error or failure (5)
▢ Other (Please Specify) (6)
▢ Unsure/ Don’t know (7)
Q27 What challenges, if any, does your Trust face in accurately recording and managing allergy information in EPR systems?
Q28 What improvements do you suggest could be made at a national level to better manage allergy information in patient records?

read more

259-2024

,

1. Please can you list the sites/locations that your Trust conducts elective surgery?
2. We are keen to understand whether your Trust are using any elective hubs – defined as exclusively performing planned surgery with ring fenced facilities and staff. Does your Trust use such a facility? If so, please list out the locations?
3. Are any of the elective hubs that you use managed by a different Trust?
4. Please could you list any Community Diagnostic Centres that your Trust makes use of that are located away from your acute hospital sites?

read more

260-2024

,

Is FERN still operational and comprised of the same team members?
If yes, is this not counter to NHS England’s position statement that police should not be involved in care?
If no, what has replaced it and how has police involvement in care been “eradicated” as mandated by NHS England?

read more

238-2024

,

1. Tetrabenazine usage. I am trying to determine the disease areas for the usage of Tetrabenazine.
Therefore, where possible to split the usage between the following disease areas:

Huntington’s Disease
Tardive Dyskinesia
Parkinson’s disease
Medication induced Dystonia

2. I am also trying to define the treatment sites for mental health provision within both the hospital and community settings, e.g.

read more

221-2024

,

All available treatment pathways for patients with eating disorders in the Trust’s various specialist services (e.g. inpatient / day patient / community)?
The number of eating disorder patients in total on each available pathway and in each available setting so far this year and in each of the past 5 years.
The number of patients in total with an eating disorder that have died of any cause so far this year and in each of the past 5 years.
Of the patients in question three, above, please provide the location in which the death occurred, for example, in an acute hospital, in the Specialist Eating Disorder Unit, in a palliative care setting, elsewhere in the Trust, or outside any Trust setting.
Please provide a copy of your Trust’s SEED (Severe and Enduring Eating disorder) pathway or similar pathway for patients with long-standing eating disorders.

read more

236-2024

,

How many patients have been treated through the Gloucestershire Health and Care NHS Foundation Trust’s post-COVID service, and what ethnic groups are they a part of? Please can you break down the numbers year by year since the service started to the present day.
How many patients remained on the waiting list each month for the service, and what ethnic groups are they a part of? Please can you break down the numbers year by year since the service started to the present day.
How many staff have been designated to your post-COVID service each year since the service started to the present day?

read more

064-2024

, ,

Please provide Electro Convulsive Treatment (ECT) information under the FOI act to the following questions: –
1.Please supply patient’s information ECT leaflet
2.Please supply patient ECT consent form
3.Please supply any ECT reports/investigations
4.How many ECT in 2023?
5.What proportion of patients were men/women?
6.How old were they?
7.What proportion of patients were classified people of the global majority or racialised communities (“POC / BAME”)?
8.How many people covered by the equality act received ECT ?
9.How many people were offered talking therapy prior to ECT ?
10.How many were receiving ECT for the first time?
11.How many patients consented to ECT?
12.How many ECT complaints were investigated outside the NHS and CCG?
13.How many patients died during or 1 month after ECT and what was the cause (whether or not ECT was considered the cause)?
14.How many patients died within 6 months after ECT and what was the cause (whether or not ECT was considered the cause)?
15.How many patients died by suicide within 6 months of receiving ECT (whether or not ECT was considered the cause)?
16.How many patients have suffered complications during and after ECT and what were those complications?
17.Have there been any formal complaints from patients/relatives about ECT?
18.If so, what was their concerns?
19.How many patients report memory loss/loss of cognitive function?
20.What tests are used to assess memory loss/loss of cognitive function?
21.Have MRI or CT scans been used before and after ECT?
22.If so, what was the conclusion?
23.How does the Trust plan to prevent ECT in the future?

Please provide restraints information under the FOI act to the following questions: –
1.Please supply any Restraints/investigations
2.How many RESTRAINTS in 2023?
3.What proportion of patients were men/women?
4.How old were they?
5.What proportion of patients were classified people of the global majority or racialised communities (“POC / BAME”)?
6.How many people covered by the equality act were restrained?
7.How many RESTRAINTS were investigated outside the NHS and CCG?
8.How many patients died during or 1 month after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?
9.How many patients died within 6 months after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?
10.How many patients died by suicide within 6 months of receiving RESTRAINTS (whether or not RESTRAINTS was considered the cause)?
11.How many patients have suffered complications during and after RESTRAINTS and what were those complications?
12.Have there been any formal complaints from patients/relatives about RESTRAINTS?
13.If so, what was their concerns?
14.Are counts of forced injections available?
15.How does the Trust plan to reduce restraints in the future?

Please provide SECLUSION information under the FOI act to the following questions: –
1.Please supply any SECLUSION reports/investigations
2.How many SECLUSIONS in 2023?
3.What proportion of patients were men/women?
4.How old were they?
5.What proportion of patients were classified people of the global majority or racialised communities (“POC / BAME”)?
6.How many people covered by the Equality Act were secluded ?
7.How many SECLUSIONS were investigated outside the NHS and CCG?
8.How many patients died during or 1 month after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?
9.How many patients died within 6 months after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?
10.How many patients died by suicide within 6 months of receiving SECLUSION (whether or not SECLUSION was considered the cause)?
11.How many patients have suffered complications during and after SECLUSION and what were those complications?
12.Have there been any formal complaints from patients/relatives about SECLUSION?
13.If so, what was their concerns?
14.How does the Trust plan to reduce SECLUSIONS in the future?

Please provide MEDICATION ERRORS information under the FOI act to the following questions: –
1.Please supply any MEDICATION ERRORS reports/investigations
2.How many MEDICATION ERRORS in 2023?
3.What proportion of patients were men/women?
4.How old were they?
5.What proportion of patients were classified people of the global majority or racialised communities (“POC / BAME”)?
6.How many people covered by the equality act endured medication errors ?
7.How many MEDICATION ERRORS were investigated outside the NHS and CCG?
8.How many patients died during or 1 month after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?
9.How many patients died within 6 months after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?
10.How many patients died by suicide within 6 months of receiving MEDICATION ERRORS (whether or not MEDICATION ERRORS was considered the cause)?
11.How many patients have suffered complications during and after MEDICATION ERRORS and what were those complications?
12.Have there been any formal complaints from patients/relatives about MEDICATION ERRORS?
13.If so, what was their concerns?
14.How does the Trust plan to prevent MEDICATION ERRORS in the future?

read more

216-2024

, ,

SECTION 1: Hospital Demographics
1. Please indicate your trust/hospital type and type of care:

1. Trust/Hospital Type:
i) Acute
ii) Mental Health
iii) Community
iv) Ambulance
v) Other (please specify)

2. Type of Care:
i) Secondary
ii) Tertiary
iii) Other (please specify)

3. Total Number of Beds: Please indicate the total number of inpatient beds in your hospital, including all types (e.g., general, ICU, maternity) if applicable.

4. ICU/ITU Bed Count: How many beds are designated for intensive or high-dependency care?

5. Annual Admissions: Please provide the total number of patient admissions in the last calendar year. If exact figures are unavailable, please provide your best estimate.

SECTION 2: Procurement and Inventory Management
1. Formal Procurement Policies: Does your hospital have formal policies or guidelines for medical equipment procurement?
i) Yes (please provide a copy or summary)
ii) No

2. Designated Procurement Roles: Is there a designated individual or team responsible for managing the procurement of medical equipment? If yes, please provide the role(s) and a brief description of responsibilities.
i) Yes – Individual
ii) Yes – Team
iii) No

3. Inventory Review Frequency: How often is your medical equipment inventory reviewed for excess or unused items?
i) Monthly
ii) Quarterly
iii) Biannually
iv) Annually
v) Other (please specify)

4. Primary Sources for Procurement:
What are the primary sources for your medical equipment procurement?
Please indicate the proportion sourced from the NHS supply chain versus individual suppliers, and provide any additional details as applicable.

SECTION 3: Waste and Disposal
1. Excess/Expired Equipment:
What percentage of your medical equipment inventory was classified as excess, unused, or expired in the last 12 months?
Please provide a breakdown by equipment type, if available.

2. Disposal Responsibility: Is there a specific role or department responsible for overseeing the disposal of medical equipment? If yes, please provide the role(s) and responsibilities.
i) Yes – Individual
ii) Yes – Department
iii) No

3. Formal Disposal Policy: Does your hospital have a formal policy for the disposal of medical equipment?
i) Yes (please provide a copy or summary of any policies)
ii) No

4. Types of Commonly Disposed Equipment: Please specify the types of medical equipment most commonly disposed of due to expiry or non-use. Include examples and approximate percentages for each type, if possible.
i) Surgical instruments
ii) Diagnostic devices
iii) Monitoring equipment
iv) Imaging equipment
v) Other (please specify)

SECTION 4: Sustainability and Environmental Impact
1. Sustainability Initiatives: Does your hospital have a sustainability initiative for recycling, reuse, or redistribution of excess or unused medical equipment?
i) Yes (please provide details)
ii) No

2. Disposal of Excess or Expired Equipment: How does your hospital manage the disposal of excess, expired, or damaged equipment? Please provide a breakdown by disposal method and indicate the approximate amount (in tonnes) used per year for each method.
i) Recycling
ii) Donation
iii) General waste
iv) Other (please specify)

SECTION 5: Policies and Compliance
1. Compliance with Disposal Guidelines: How does your hospital ensure compliance with national or NHS guidelines on the disposal and management of medical equipment?
i) Internal audits
ii) External audits
iii) Regular staff training
iv) Other (please specify)

2. Internal Audits of Equipment Management: Has your hospital conducted internal audits within the last 12 months to assess the management of excess medical equipment?
i) Yes (If yes, please indicate the frequency of audits and any key findings, if available)
ii) No

read more

220-2024

,

Please could you give us current information in relation to how prostate cancer patients are managed when they are eligible for active surveillance/monitoring. Including:

Inclusion criteria

Diagnosis and treatment decision support

Follow-up pathways and protocols

Follow-up testing frequencies

Triggers for stopping active surveillance

read more

196-2024

,

In an Excel spreadsheet with information for Q 6 – 21 broken down by each pathology provider in your trust
1. What is the size of your trust’s serviceable population?
2. How many patients has the trust tested for the following clinical biochemical markers in the last 12 months?
a. C-reactive protein (CRP)
b. High-sensitivity C-reactive protein (hs-CRP)
c. Lipoprotein-a (Lp(a))
3. Is there a limit to the frequency of the following tests per patient?
a. C-reactive protein (CRP)
b. High-sensitivity C-reactive protein (hs-CRP)
c. Lipoprotein-a (Lp(a))
4. Please provide the name and post code of all the pathology providers in your trust
5. Do you outsource any testing to commercial labs? If yes, please provide the names of each commercial provider
Please answer the following questions for each pathology provider in your trust
6. Does the laboratory currently offer testing for the following?
a. C-reactive protein (CRP)
b. High-sensitivity C-reactive protein (hs-CRP)
c. Lipoprotein-a (Lp(a))
7. What is the average turnaround time for an outpatient from blood sample collection to sharing of results for CRP and hs-CRP?
8. Is CRP offered as a standalone test or part of a panel?
9. Is hs-CRP offered as a standalone test or part of a panel?
10. What machines are used to conduct CRP testing in your laboratory?
11. What machines are used to conduct hs-CRP testing in your laboratory?
12. What is the lowest limit of detection (in mg/L) that you report for CRP?
13. What is the lowest limit of detection (in mg/L) that you report for hs-CRP?
14. How many requests for measurement of CRP did your laboratory complete in the last 12 months?
15. How many requests for measurement of hs-CRP did your laboratory complete in the last 12 months?
16. What is the maximum number of CRP tests that your laboratory can conduct in one month?
17. What is the maximum number of hs-CRP tests that laboratory can conduct in one month?
18. What is the cost of running a single CRP test in your laboratory? Please provide a breakdown of cost of running the test and all-in cost considering operations, FTEs etc.
19. What is the cost of running a single hs-CRP test in your laboratory? Please provide a breakdown of cost of running the test and all-in cost considering operations, FTEs etc.
20. How much are you reimbursed for a single CRP test in your laboratory?
21. How much are you reimbursed for a single hs-CRP test in your laboratory?

read more

200-2024

,

1. Does Gloucestershire Health and Care NHS Foundation Trust use single use endoscopes for any of its endoscopy procedures?
a. If so, can you state in which procedures they are used?
b. If so, can you state which brand/s of endoscopes are used?

2. Can Gloucestershire Health and Care NHS Foundation Trust state how many single use endoscopes have been used in 2021, 2022, 2023 and 2024?

3. Can Gloucestershire Health and Care NHS Foundation Trust state how many single use endoscopes are planned to be used in 2024, 2025, and 2026.

4. Does Gloucestershire Health and Care NHS Foundation Trust have plans to increase the use of single use endoscopes to help in the delivery of Community Diagnostic Centres and temporary out-of-hours hubs to reduce waiting lists?

read more

172-2024

1. How many Long Covid Clinics for Adults are there within your Trust?
2. How many Long Covid Clinics for Children are there within your Trust?
3. Can you list each Long Covid Clinic for Adults within your Trust?
4. Can you list each Long Covid Clinic for Children within your Trust?
5. If you have no Long Covid Clinics for Adults within your Trust, what services do you provide for Adults?
6. If you have no Long Covid Clinics for Children within your Trust, what services do you provide for Children?

read more

167-2024

,

1. How is waitlist validation carried out in your Trusts? Please select one of the following options: Manually / Semi-automated / Automated.
a. If your response was semi-automated or automated, which tools do you use? Please specify the types of tools or software used.
2. How many FTEs currently work on waitlist validation and what band are they? Please specify the number per band.
3. How has your FTE count working on waitlist validation increased in the past 2-3 years? Please provide an estimate if you do not have the exact number.
4. In the past 12 months, approximately how long has the waitlist validation process taken? Please provide an estimate if you do not have the exact number.
5. What data quality issues have been identified the most frequently as part of the waitlist validation process? Please select those that apply from the list below:
a. Decision to admit but no waiting list entry
b. Missing waiting list or pathway information (e.g. due date, intended procedure)
c. Patients on an admitted waiting list without an active RTT (Referral to Treatment Pathway) clock
d. Past TCI (To Come In) dates
e. Potential duplicates
f. Other – please specify
6. What are your current approaches to linking data? Please select one of the following options: Manually or semi-automated / Automated
7. What is the proportion of data linkage that is manual and automated? Please provide an estimate if you do not have the exact number.
a. If automated, what tools are used? Please provide the name of the tools.
b. If manual, what tools are used e.g. R, data bricks? Please provide the name of the tools.
8. Currently, is the data linking process cumbersome? Please select one option: Yes/No
9. And does it take away from people’s everyday role? Please select one option: Yes/No

read more

TEST 027-2023

,

Under the FOI Act please provide me with the information below. Please confirm receipt of this request as soon as possible. The number of inpatients who are currently medically fit to leave hospital in your area, but still reside there. Please provide this as a series of data points for the last calendar year and the year to date, broken down by day. For each day, please break the data into further categories which detail the reason behind the delayed discharge.  I am aware that some of the data showing the total number of delayed transfers of care is published here: https://www.england.nhs.uk/statistics/statistical-work-areas/discharge-delays-acute-data/ however I am looking for further information relating to the cause of the discharge delay.  For example, the Welsh Government also used to publish a detailed breakdown of reasons behind delayed discharge - https://statswales.gov.wales/Catalogue/Health-and-Social-Care/NHS-Performance/Delayed-Transfers-of-Care     By way of illustration, a response may look like this:    01/01/22 - 100 people awaiting discharge, 20 awaiting physiotherapy, 30 awaiting transport home, 50 awaiting care packages 02/01/22 – 90 people awaiting discharge, 15 awaiting physiotherapy, 30 awaiting transport home, 45 awaiting care packages And so on….   Please provide this data in a spreadsheet format such as excel or a .csv file, with columns for the date, total number of patients and reasons for delay.

read more